Date: Monday, 29th June 2015
Time: 1:00pm Central European Time, 7:00am Eastern Standard Time, 4:30pm Indian Standard Time
(check www.timeanddate.com for your local time)
Duration: 60 minutes
To register, click here
Ending tuberculosis (TB) is possible only when we accurately diagnose TB early, treat the person with drugs-that-work, help support adherence and address other issues as per the WHO End TB Strategy.
This study assessed the impact of up-front Xpert MTB/RIF testing on detection of pulmonary tuberculosis (PTB) and rifampicin-resistant PTB (DR-TB) cases in India. The study results provide a solid rationale/ evidence on how important it could be for progressing towards ending TB.
This webinar will provide you an opportunity to have a direct interface with study author(s), lead TB experts from the World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (The Union). Learn about study findings and ask questions from the experts!
About the Experts:
- [Presentation] Dr KS Sachdeva, Study co-author and Additional Director General, Central TB Division, Ministry of Health and Family Welfare, Government of India
- [Presentation] Dr Sarabjit S Chadha, Project Director, International Union Against Tuberculosis and Lung Disease (The Union)
- Dr Mario Raviglione, Director, World Health Organization (WHO)'s Global TB Programme
We look forward to hearing your voices and questions in this discussion. And, as always, please email us at email@example.com with questions, comments and suggestions.
Citizen News Service (CNS) Webinars team